Maxim Group Reaffirms Hold Rating for Galmed Pharmaceuticals (NASDAQ:GLMD)
Maxim Group restated their hold rating on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report sent to investors on Friday,Benzinga reports. Separately, StockNews.com assumed coverage on shares of Galmed Pharmaceuticals in a research report on Friday, March 28th. They set a “sell” rating on the stock. View Our Latest Stock Analysis […]
Maxim Group restated their hold rating on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report sent to investors on Friday,Benzinga reports. Separately, StockNews.com assumed coverage on shares of Galmed Pharmaceuticals in a research report on Friday, March 28th. They set a “sell” rating on the stock. View Our Latest Stock Analysis […]